Reporting of adverse events ONLY

Patients should always seek the advice of a doctor or pharmacist in case of adverse events. If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:

Telephone: 00420 224 910 672 (from 09.00-17.30 CET)
Cell phone: 00420 723 694 460 (non-stop 24/7)

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod. Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

Telefon: 00420 224 910 672 (09.00-17.30 CET)
Mobilní telefon: 00420 723 694 460 (non-stop 24/7)


From Concept to Commercialisation is one of the key partnership areas in which ELC GROUP is creating its fast-growing success.
From the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product, ELC GROUP aligns itself as a strategic partner to help pharmaceutical companies achieve their healthcare goals.


ELC Group to showcase regulatory affairs solutions at CPhI events in Shanghai and Barcelona - 3rd June 2016

CPhI China in Shanghai from June 21st - 23rd 2016 and CPhI Worldwide in Barcelona, Spain, from October 4th – 6th More

ELC Group in early-stage development of novel influenza vaccine - 16th June 2015

1 million Euro project marks regulatory affairs provider’s entry into pharmaceutical development market More

ELC Group expands into pharmaceutical product development market - 9th June 2015

Fast-growing regulatory affairs provider creating extensive product portfolio for sale across US, EU, LATAM, MENA and China More

Case Studies

Referral Management Service

When this generic international pharmaceutical company found its promising pan-European license application suddenly encountering an unexpected problem, it turned to ELC to navigate the complex referral process and get back on track to achieve the all-important approvals it needed to go to market.

Scientific Advice Service

When an Asia-based pharmaceutical company wanted to speed time-to-market for its generic to a leading brand-name drug, it engaged ELC Group to help to get the product successfully launched in European markets on its first submission – and as the first in its market.

Complete Pharmacovigilance

A generic pharmaceutical company looked to ELC Group’s experience and expert knowledge to help reduce operational costs, meet key regulatory deadlines and ensure continuing compliance across its global portfolio of products.